- Beranda
- Komunitas
- Trading Systems
- LUX StockPicker
LUX StockPicker (By forex_trader_198702)
LUX StockPicker Discussion
Our copytrading signal is built on a solid mix of technical and fundamental analysis. We invest in quality stocks — and yes, that comes with volatility.
It’s impossible to invest in the stock market without it. Anyone promising “zero volatility” or “only green days”… run away. Volatility and drawdowns are simply part of the game.
The real edge? With proper risk management and money management, you can stay 100% calm even when the market tests us. That peace of mind is exactly what makes this signal special.
Current Positions Update:
NFLX (Netflix) → in a short-term pullback
Backed by strong fundamentals: Revenue (ttm) of $45.18B, Net Income (ttm) of $10.98B, a healthy Profit Margin of 24.3%, and Quarterly Revenue Growth (yoy) of 17.6%. Trading at a Trailing P/E of 32.49 and Forward P/E of 26.04, it's well below fair value given its growth trajectory.
ALNY (Alnylam Pharmaceuticals) → also experiencing some pressure
Supported by exceptional fundamentals: Revenue (ttm) of $3.21B with an astounding Quarterly Revenue Growth (yoy) of 149.3%, Net Income (ttm) of $43.56M, and Operating Margin (ttm) of 29.46%. With a Forward P/E of 45.05, this reflects high growth potential in its innovative biotech pipeline.
But here’s the key: these are exceptional buys.
Both companies have extremely solid fundamentals and are trading at prices well below their fair valuations. The business quality and long-term potential remain outstanding. We are 100% comfortable holding and even adding at these levels.
🎯 Opportunity for New Copiers:
This is actually a fantastic moment to join.
If you start copying now and activate the option to copy open positions, you will enter NFLX and ALNY at very attractive prices. The potential profit on these trades from current levels can be very significant.
Smart money buys strength on weakness — this is one of those moments.
We continue to manage the portfolio with discipline and conviction.
Thank you for trusting the process. Volatility is temporary. Quality and patience are permanent.
Any questions? Drop them below 👇
Let’s keep building together.
LUX StockPicker Update!!!
Big win on NFLX! 🚀
We just closed our Netflix positions for a clean +4.65% boost to the account. 💰
Timed it perfectly on Friday (Feb 27), riding that strong bullish surge and now sitting with high liquidity — fully protected and ready to take advantage of the pullbacks we expect next week. 📉 → 📈
Solid combo of fundamental + technical analysis, smart rotation, and strict risk control.
Building long-term wealth the right way — consistent and low drama!
Ready for what’s next? 🔥
#LuxStockPicker #Trading #Netflix #Stocks #Investing
🚀 New Position Opened: CHTR 🚀
We’ve just opened a new position in Charter Communications (CHTR), one of the highest-quality companies in the U.S. telecom and broadband sector.
📈 Technical Setup
From a technical perspective, CHTR is showing a very attractive setup. After a prolonged consolidation phase, the stock is stabilizing near key support levels while momentum indicators are beginning to turn upward. This type of structure often precedes strong directional moves, especially when combined with improving sentiment.
The risk/reward profile at current levels is very compelling, offering the potential for a significant upside move if the stock confirms a new bullish trend.
🧠 Fundamental Thesis
On the fundamental side, Charter Communications remains a top-tier company:
• 📡 Dominant broadband infrastructure across the United States
• 💰 Strong cash flow generation
• 📊 Attractive valuation compared with its historical multiples
• 🔁 Shareholder returns through share buybacks
• 📶 Structural demand growth for high-speed internet and connectivity
Despite short-term market concerns around the telecom sector, the long-term outlook for high-quality broadband providers remains very strong.
🌍 Long-Term Opportunity
We believe CHTR has significant upside potential over the coming years. The company operates in an essential infrastructure segment with durable demand and high barriers to entry — characteristics that define true compounder businesses.
This is exactly the type of high-quality stock with large upside potential we like to add to the portfolio.
Stay tuned for updates as the position develops. 📊
#Investing #Stocks #CopyTrading #LongTermInvesting #StockMarket #CHTR #QualityStocks #ValueInvesting #Telecom #InvestmentStrategy 📈
🚀 Position Added: Increasing Exposure to ALNY 🚀
We’ve added to our position in Alnylam Pharmaceuticals (ALNY), reinforcing our conviction in one of the most innovative companies in the biotechnology sector.
📈 Technical Perspective
From a technical standpoint, ALNY is currently trading in a very interesting zone. After a corrective phase and consolidation, the stock is stabilizing around important support levels.
This type of price action often creates strong asymmetric opportunities, where downside risk is limited while the upside potential can be substantial if the trend resumes. Adding here allows us to improve our average entry while positioning for a potential medium- to long-term move higher.
🧬 Fundamental Thesis
Our conviction in Alnylam remains very strong:
• 🧪 Global leader in RNA interference (RNAi) therapeutics
• 💊 Multiple approved drugs already generating revenue
• 📊 Robust pipeline with several potential blockbuster therapies
• 🤝 Strategic partnerships with major pharmaceutical companies
• 🌍 Addressing serious and rare diseases with high unmet medical need
Alnylam is not just another biotech company — it is a platform biotech with transformational technology that could reshape how many diseases are treated.
🌟 Long-Term Potential
We believe ALNY has the potential to become one of the most valuable biotech platforms of the next decade as its pipeline matures and more therapies reach the market.
By adding to the position, we are reinforcing our long-term thesis and taking advantage of what we believe is an attractive opportunity in a high-quality growth company.
#Investing #Biotech #Stocks #CopyTrading #LongTermInvesting #ALNY #Biotechnology #GrowthStocks #Innovation #StockMarket 🧬📈